Er: YAG Laser Treatment of Verrucous Epidermal Nevi

Jae Hong Park, Eul Sang Hwang, Soo Nam Kim, Young Chul Kye

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

BACKGROUND. The term verrucous epidermal nevi refers to benign hyperplasia of the epidermis. Numerous treatment modalities have been tried, but no ideal treatment is yet available. We would like to present our experience with Er:YAG laser ablation in the treatment of verrucous epidermal nevi. OBJECTIVE. The purpose of this study is to assess the long-term results of Er:YAG laser treatment of verrucous epidermal nevi. METHODS. Twenty patients with verrucous epidermal nevi were treated with Er:YAG laser. Twelve patients were treated with the variable-pulsed Er:YAG laser, a 5-mm handpiece at the setting of 7.0 to 7.5J/cm2, at a 500-μs pulse duration. The dual-mode Er:YAG laser, with a 2-mm handpiece at the setting of 6.3J/cm2, at a 350-μs pulse duration (25 microns ablation), was used in eight patients. The laser was fired at 5 Hz until all epidermal nevi were removed. The results of treatment were evaluated for the changes of skin lesions, texture, and color by physicians over a 24-month period. RESULTS. After a single laser treatment, successful elimination of the verrucous epidermal nevi was observed in 15 patients. Five patients (25%) showed a relapse within 1 year after the treatment. Postoperative healing time was 7 to 10 days. Erythema occurred in all patients after the laser treatment and subsided in 2 months. Postinflammatory hyperpigmentation occurred in two patients (10%). One patient (5%) experienced transient hypopigmentation. Mild to moderate postoperative acne flare-up occurred in one patient (5%) with facial lesions. No other adverse effects, including scarring, were observed. CONCLUSION. The Er:YAG laser ablation is an effective, safe, and nonscarring method for the treatment of verrucous epidermal nevi.

Original languageEnglish
Pages (from-to)378-381
Number of pages4
JournalDermatologic Surgery
Volume30
Issue number3
DOIs
Publication statusPublished - 2004 Mar 1

Fingerprint

Sebaceous of Jadassohn Nevus
Solid-State Lasers
Lasers
Therapeutics
Laser Therapy
Hypopigmentation
Hyperpigmentation
Acne Vulgaris
Erythema
Epidermis
Hyperplasia
Cicatrix
Color

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Er : YAG Laser Treatment of Verrucous Epidermal Nevi. / Park, Jae Hong; Hwang, Eul Sang; Kim, Soo Nam; Kye, Young Chul.

In: Dermatologic Surgery, Vol. 30, No. 3, 01.03.2004, p. 378-381.

Research output: Contribution to journalArticle

Park, Jae Hong ; Hwang, Eul Sang ; Kim, Soo Nam ; Kye, Young Chul. / Er : YAG Laser Treatment of Verrucous Epidermal Nevi. In: Dermatologic Surgery. 2004 ; Vol. 30, No. 3. pp. 378-381.
@article{ee841c2ac0c94c84a596165f60235279,
title = "Er: YAG Laser Treatment of Verrucous Epidermal Nevi",
abstract = "BACKGROUND. The term verrucous epidermal nevi refers to benign hyperplasia of the epidermis. Numerous treatment modalities have been tried, but no ideal treatment is yet available. We would like to present our experience with Er:YAG laser ablation in the treatment of verrucous epidermal nevi. OBJECTIVE. The purpose of this study is to assess the long-term results of Er:YAG laser treatment of verrucous epidermal nevi. METHODS. Twenty patients with verrucous epidermal nevi were treated with Er:YAG laser. Twelve patients were treated with the variable-pulsed Er:YAG laser, a 5-mm handpiece at the setting of 7.0 to 7.5J/cm2, at a 500-μs pulse duration. The dual-mode Er:YAG laser, with a 2-mm handpiece at the setting of 6.3J/cm2, at a 350-μs pulse duration (25 microns ablation), was used in eight patients. The laser was fired at 5 Hz until all epidermal nevi were removed. The results of treatment were evaluated for the changes of skin lesions, texture, and color by physicians over a 24-month period. RESULTS. After a single laser treatment, successful elimination of the verrucous epidermal nevi was observed in 15 patients. Five patients (25{\%}) showed a relapse within 1 year after the treatment. Postoperative healing time was 7 to 10 days. Erythema occurred in all patients after the laser treatment and subsided in 2 months. Postinflammatory hyperpigmentation occurred in two patients (10{\%}). One patient (5{\%}) experienced transient hypopigmentation. Mild to moderate postoperative acne flare-up occurred in one patient (5{\%}) with facial lesions. No other adverse effects, including scarring, were observed. CONCLUSION. The Er:YAG laser ablation is an effective, safe, and nonscarring method for the treatment of verrucous epidermal nevi.",
author = "Park, {Jae Hong} and Hwang, {Eul Sang} and Kim, {Soo Nam} and Kye, {Young Chul}",
year = "2004",
month = "3",
day = "1",
doi = "10.1111/j.1524-4725.2004.30104.x",
language = "English",
volume = "30",
pages = "378--381",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Er

T2 - YAG Laser Treatment of Verrucous Epidermal Nevi

AU - Park, Jae Hong

AU - Hwang, Eul Sang

AU - Kim, Soo Nam

AU - Kye, Young Chul

PY - 2004/3/1

Y1 - 2004/3/1

N2 - BACKGROUND. The term verrucous epidermal nevi refers to benign hyperplasia of the epidermis. Numerous treatment modalities have been tried, but no ideal treatment is yet available. We would like to present our experience with Er:YAG laser ablation in the treatment of verrucous epidermal nevi. OBJECTIVE. The purpose of this study is to assess the long-term results of Er:YAG laser treatment of verrucous epidermal nevi. METHODS. Twenty patients with verrucous epidermal nevi were treated with Er:YAG laser. Twelve patients were treated with the variable-pulsed Er:YAG laser, a 5-mm handpiece at the setting of 7.0 to 7.5J/cm2, at a 500-μs pulse duration. The dual-mode Er:YAG laser, with a 2-mm handpiece at the setting of 6.3J/cm2, at a 350-μs pulse duration (25 microns ablation), was used in eight patients. The laser was fired at 5 Hz until all epidermal nevi were removed. The results of treatment were evaluated for the changes of skin lesions, texture, and color by physicians over a 24-month period. RESULTS. After a single laser treatment, successful elimination of the verrucous epidermal nevi was observed in 15 patients. Five patients (25%) showed a relapse within 1 year after the treatment. Postoperative healing time was 7 to 10 days. Erythema occurred in all patients after the laser treatment and subsided in 2 months. Postinflammatory hyperpigmentation occurred in two patients (10%). One patient (5%) experienced transient hypopigmentation. Mild to moderate postoperative acne flare-up occurred in one patient (5%) with facial lesions. No other adverse effects, including scarring, were observed. CONCLUSION. The Er:YAG laser ablation is an effective, safe, and nonscarring method for the treatment of verrucous epidermal nevi.

AB - BACKGROUND. The term verrucous epidermal nevi refers to benign hyperplasia of the epidermis. Numerous treatment modalities have been tried, but no ideal treatment is yet available. We would like to present our experience with Er:YAG laser ablation in the treatment of verrucous epidermal nevi. OBJECTIVE. The purpose of this study is to assess the long-term results of Er:YAG laser treatment of verrucous epidermal nevi. METHODS. Twenty patients with verrucous epidermal nevi were treated with Er:YAG laser. Twelve patients were treated with the variable-pulsed Er:YAG laser, a 5-mm handpiece at the setting of 7.0 to 7.5J/cm2, at a 500-μs pulse duration. The dual-mode Er:YAG laser, with a 2-mm handpiece at the setting of 6.3J/cm2, at a 350-μs pulse duration (25 microns ablation), was used in eight patients. The laser was fired at 5 Hz until all epidermal nevi were removed. The results of treatment were evaluated for the changes of skin lesions, texture, and color by physicians over a 24-month period. RESULTS. After a single laser treatment, successful elimination of the verrucous epidermal nevi was observed in 15 patients. Five patients (25%) showed a relapse within 1 year after the treatment. Postoperative healing time was 7 to 10 days. Erythema occurred in all patients after the laser treatment and subsided in 2 months. Postinflammatory hyperpigmentation occurred in two patients (10%). One patient (5%) experienced transient hypopigmentation. Mild to moderate postoperative acne flare-up occurred in one patient (5%) with facial lesions. No other adverse effects, including scarring, were observed. CONCLUSION. The Er:YAG laser ablation is an effective, safe, and nonscarring method for the treatment of verrucous epidermal nevi.

UR - http://www.scopus.com/inward/record.url?scp=1942536191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942536191&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2004.30104.x

DO - 10.1111/j.1524-4725.2004.30104.x

M3 - Article

C2 - 15008864

AN - SCOPUS:1942536191

VL - 30

SP - 378

EP - 381

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 3

ER -